Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Heteroaromatic-aminomethyl quinolones: potent and selective iNOS inhibitors.

DurĂ³n SG, Lindstrom A, Bonnefous C, Zhang H, Chen X, Symons KT, Sablad M, Rozenkrants N, Zhang Y, Wang L, Yazdani N, Shiau AK, Noble SA, Rix P, Rao TS, Hassig CA, Smith ND.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):1237-41. doi: 10.1016/j.bmcl.2011.11.073. Epub 2011 Nov 25.

PMID:
22182498
2.
3.

Limitations and lessons in the use of X-ray structural information in drug design.

Davis AM, St-Gallay SA, Kleywegt GJ.

Drug Discov Today. 2008 Oct;13(19-20):831-41. doi: 10.1016/j.drudis.2008.06.006. Epub 2008 Aug 27. Review. No abstract available.

PMID:
18617015
4.

Progress in the development of selective nitric oxide synthase (NOS) inhibitors.

Salerno L, Sorrenti V, Di Giacomo C, Romeo G, Siracusa MA.

Curr Pharm Des. 2002;8(3):177-200. Review.

PMID:
11812267
5.

Recent advances in the discovery and development of quinolones and analogs as antitumor agents.

Xia Y, Yang ZY, Morris-Natschke SL, Lee KH.

Curr Med Chem. 1999 Mar;6(3):179-94. Review.

PMID:
10219099
6.

Mechanism-based profiling of enzyme families.

Evans MJ, Cravatt BF.

Chem Rev. 2006 Aug;106(8):3279-301. Review. No abstract available.

PMID:
16895328

Supplemental Content

Support Center